My experience was pain free and clinically hygienic
Next-generation compounds are also entering clinical trials
In some cases, temporarily reducing the tirzepatide dose or extending the interval between dose increases may help determine whether symptoms are medication-related
This reflects the stronger evidence base and clearer medical necessity criteria for diabetes
A trial published in the New England Journal of Medicine found that participants using tirzepatide lost up to 20.9% of their body weight over 72 weeks, with outcomes improving at higher doses across all treatment groups (Jastreboff et al., NEJM, 2022, Washington residents across the state, from Seattle to Spokane and everywhere in between, have real and practical access to tirzepatide today
Once you have achieved a desired outcome, transitioning to a maintenance dose can help sustain progress